New appointment at Tris Pharma
This article was originally published in Scrip
Tris Pharma (US), a speciality pharmaceutical company focused on the development of drug delivery technologies, has appointed Peter Ciano vice-president of corporate development. He has been working for Tris as a business development consultant for more than eighteen months, and will now lead and manage the company's commercial activities for its brand side of the business.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.